7 assets in Chromosomal Disorder

Therapeutic assets addressing Chromosomal Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Busulfanum Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Melphalan Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Rituximab Chromosomal Disorder	Masonic Cancer Center, University of Minnesota	P2	CCC (53)